Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Other Operating Expense : $-0.11 Mil (TTM As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Other Operating Expense?

Parnell Pharmaceuticals Holdings's Other Operating Expense for the six months ended in Dec. 2018 was $-0.11 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2018 was $-0.11 Mil.

Parnell Pharmaceuticals Holdings's quarterly Other Operating Expense increased from Dec. 2016 ($-0.73 Mil) to Dec. 2017 ($-0.51 Mil) and increased from Dec. 2017 ($-0.51 Mil) to Dec. 2018 ($-0.11 Mil).

Parnell Pharmaceuticals Holdings's annual Other Operating Expense increased from Dec. 2016 ($-0.73 Mil) to Dec. 2017 ($-0.51 Mil) and increased from Dec. 2017 ($-0.51 Mil) to Dec. 2018 ($-0.11 Mil).

Parnell Pharmaceuticals Holdings Other Operating Expense Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Other Operating Expense Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Other Operating Expense

Get a 7-Day Free Trial

-0.73

-0.51

-0.11

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Other Operating Expense	Get a 7-Day Free Trial			-	-	-0.73	-0.51	-0.11

Parnell Pharmaceuticals Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2018 was $-0.11 Mil.

Parnell Pharmaceuticals Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.